For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.

The global Cancer Biopsy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Cancer Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cancer Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cancer Biopsy in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cancer Biopsy include Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher and Lucence Diagnostics Pte. Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biopsy.

Report Scope

The Cancer Biopsy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Biopsy Market Report

Report Metric	Details
Report Name	Cancer Biopsy Market
Segment by Type	Tissue Biopsies Liquid Biopsies Others
Segment by Application	Breast Cancer Colorectal Cancer Cervical Cancers Lung Cancers Prostate Cancers Skin Cancers Blood Cancers Kidney Cancers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, Lucence Diagnostics Pte. Ltd., GRAIL, Inc., Guardant Health, Exact Sciences Corporation, Freenome Holdings, Inc., Oncimmune, Chronix Biomedical, Inc., Personal Genome Diagnostics Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Biopsy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Biopsy Market report?

Ans: The main players in the Cancer Biopsy Market are Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, Lucence Diagnostics Pte. Ltd., GRAIL, Inc., Guardant Health, Exact Sciences Corporation, Freenome Holdings, Inc., Oncimmune, Chronix Biomedical, Inc., Personal Genome Diagnostics Inc.

What are the Application segmentation covered in the Cancer Biopsy Market report?

Ans: The Applications covered in the Cancer Biopsy Market report are Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Others

What are the Type segmentation covered in the Cancer Biopsy Market report?

Ans: The Types covered in the Cancer Biopsy Market report are Tissue Biopsies, Liquid Biopsies, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Biopsy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Tissue Biopsies

1.2.3 Liquid Biopsies

1.2.4 Others

1.3 Market by Application

1.3.1 Global Cancer Biopsy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Colorectal Cancer

1.3.4 Cervical Cancers

1.3.5 Lung Cancers

1.3.6 Prostate Cancers

1.3.7 Skin Cancers

1.3.8 Blood Cancers

1.3.9 Kidney Cancers

1.3.10 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Biopsy Market Perspective (2019-2030)

2.2 Cancer Biopsy Growth Trends by Region

2.2.1 Global Cancer Biopsy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer Biopsy Historic Market Size by Region (2019-2024)

2.2.3 Cancer Biopsy Forecasted Market Size by Region (2025-2030)

2.3 Cancer Biopsy Market Dynamics

2.3.1 Cancer Biopsy Industry Trends

2.3.2 Cancer Biopsy Market Drivers

2.3.3 Cancer Biopsy Market Challenges

2.3.4 Cancer Biopsy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Biopsy Players by Revenue

3.1.1 Global Top Cancer Biopsy Players by Revenue (2019-2024)

3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2019-2024)

3.2 Global Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Biopsy Revenue

3.4 Global Cancer Biopsy Market Concentration Ratio

3.4.1 Global Cancer Biopsy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopsy Revenue in 2023

3.5 Cancer Biopsy Key Players Head office and Area Served

3.6 Key Players Cancer Biopsy Product Solution and Service

3.7 Date of Enter into Cancer Biopsy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Biopsy Breakdown Data by Type

4.1 Global Cancer Biopsy Historic Market Size by Type (2019-2024)

4.2 Global Cancer Biopsy Forecasted Market Size by Type (2025-2030)

5 Cancer Biopsy Breakdown Data by Application

5.1 Global Cancer Biopsy Historic Market Size by Application (2019-2024)

5.2 Global Cancer Biopsy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer Biopsy Market Size (2019-2030)

6.2 North America Cancer Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cancer Biopsy Market Size by Country (2019-2024)

6.4 North America Cancer Biopsy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Biopsy Market Size (2019-2030)

7.2 Europe Cancer Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cancer Biopsy Market Size by Country (2019-2024)

7.4 Europe Cancer Biopsy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Biopsy Market Size (2019-2030)

8.2 Asia-Pacific Cancer Biopsy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cancer Biopsy Market Size by Region (2019-2024)

8.4 Asia-Pacific Cancer Biopsy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Biopsy Market Size (2019-2030)

9.2 Latin America Cancer Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cancer Biopsy Market Size by Country (2019-2024)

9.4 Latin America Cancer Biopsy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Biopsy Market Size (2019-2030)

10.2 Middle East & Africa Cancer Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cancer Biopsy Market Size by Country (2019-2024)

10.4 Middle East & Africa Cancer Biopsy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Qiagen N.V.

11.1.1 Qiagen N.V. Company Detail

11.1.2 Qiagen N.V. Business Overview

11.1.3 Qiagen N.V. Cancer Biopsy Introduction

11.1.4 Qiagen N.V. Revenue in Cancer Biopsy Business (2019-2024)

11.1.5 Qiagen N.V. Recent Development

11.2 Illumina, Inc.

11.2.1 Illumina, Inc. Company Detail

11.2.2 Illumina, Inc. Business Overview

11.2.3 Illumina, Inc. Cancer Biopsy Introduction

11.2.4 Illumina, Inc. Revenue in Cancer Biopsy Business (2019-2024)

11.2.5 Illumina, Inc. Recent Development

11.3 ANGLE Plc

11.3.1 ANGLE Plc Company Detail

11.3.2 ANGLE Plc Business Overview

11.3.3 ANGLE Plc Cancer Biopsy Introduction

11.3.4 ANGLE Plc Revenue in Cancer Biopsy Business (2019-2024)

11.3.5 ANGLE Plc Recent Development

11.4 Myriad Genetics

11.4.1 Myriad Genetics Company Detail

11.4.2 Myriad Genetics Business Overview

11.4.3 Myriad Genetics Cancer Biopsy Introduction

11.4.4 Myriad Genetics Revenue in Cancer Biopsy Business (2019-2024)

11.4.5 Myriad Genetics Recent Development

11.5 Hologic, Inc.

11.5.1 Hologic, Inc. Company Detail

11.5.2 Hologic, Inc. Business Overview

11.5.3 Hologic, Inc. Cancer Biopsy Introduction

11.5.4 Hologic, Inc. Revenue in Cancer Biopsy Business (2019-2024)

11.5.5 Hologic, Inc. Recent Development

11.6 Biocept, Inc.

11.6.1 Biocept, Inc. Company Detail

11.6.2 Biocept, Inc. Business Overview

11.6.3 Biocept, Inc. Cancer Biopsy Introduction

11.6.4 Biocept, Inc. Revenue in Cancer Biopsy Business (2019-2024)

11.6.5 Biocept, Inc. Recent Development

11.7 Thermo Fisher Scientific, Inc.

11.7.1 Thermo Fisher Scientific, Inc. Company Detail

11.7.2 Thermo Fisher Scientific, Inc. Business Overview

11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Introduction

11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2019-2024)

11.7.5 Thermo Fisher Scientific, Inc. Recent Development

11.8 Danaher

11.8.1 Danaher Company Detail

11.8.2 Danaher Business Overview

11.8.3 Danaher Cancer Biopsy Introduction

11.8.4 Danaher Revenue in Cancer Biopsy Business (2019-2024)

11.8.5 Danaher Recent Development

11.9 Lucence Diagnostics Pte. Ltd.

11.9.1 Lucence Diagnostics Pte. Ltd. Company Detail

11.9.2 Lucence Diagnostics Pte. Ltd. Business Overview

11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Introduction

11.9.4 Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2019-2024)

11.9.5 Lucence Diagnostics Pte. Ltd. Recent Development

11.10 GRAIL, Inc.

11.10.1 GRAIL, Inc. Company Detail

11.10.2 GRAIL, Inc. Business Overview

11.10.3 GRAIL, Inc. Cancer Biopsy Introduction

11.10.4 GRAIL, Inc. Revenue in Cancer Biopsy Business (2019-2024)

11.10.5 GRAIL, Inc. Recent Development

11.11 Guardant Health

11.11.1 Guardant Health Company Detail

11.11.2 Guardant Health Business Overview

11.11.3 Guardant Health Cancer Biopsy Introduction

11.11.4 Guardant Health Revenue in Cancer Biopsy Business (2019-2024)

11.11.5 Guardant Health Recent Development

11.12 Exact Sciences Corporation

11.12.1 Exact Sciences Corporation Company Detail

11.12.2 Exact Sciences Corporation Business Overview

11.12.3 Exact Sciences Corporation Cancer Biopsy Introduction

11.12.4 Exact Sciences Corporation Revenue in Cancer Biopsy Business (2019-2024)

11.12.5 Exact Sciences Corporation Recent Development

11.13 Freenome Holdings, Inc.

11.13.1 Freenome Holdings, Inc. Company Detail

11.13.2 Freenome Holdings, Inc. Business Overview

11.13.3 Freenome Holdings, Inc. Cancer Biopsy Introduction

11.13.4 Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2019-2024)

11.13.5 Freenome Holdings, Inc. Recent Development

11.14 Oncimmune

11.14.1 Oncimmune Company Detail

11.14.2 Oncimmune Business Overview

11.14.3 Oncimmune Cancer Biopsy Introduction

11.14.4 Oncimmune Revenue in Cancer Biopsy Business (2019-2024)

11.14.5 Oncimmune Recent Development

11.15 Chronix Biomedical, Inc.

11.15.1 Chronix Biomedical, Inc. Company Detail

11.15.2 Chronix Biomedical, Inc. Business Overview

11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Introduction

11.15.4 Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2019-2024)

11.15.5 Chronix Biomedical, Inc. Recent Development

11.16 Personal Genome Diagnostics Inc.

11.16.1 Personal Genome Diagnostics Inc. Company Detail

11.16.2 Personal Genome Diagnostics Inc. Business Overview

11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Introduction

11.16.4 Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2019-2024)

11.16.5 Personal Genome Diagnostics Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific Inc

Danaher

Lucence Diagnostics Pte. Ltd.

GRAIL

Guardant Health

Exact Sciences Corporation

Freenome Holdings, Inc.

Oncimmune

Chronix Biomedical, Inc.

Personal Genome Diagnostics, Inc.

List of Tables

Table 1. Global Cancer Biopsy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Tissue Biopsies

Table 3. Key Players of Liquid Biopsies

Table 4. Key Players of Others

Table 5. Global Cancer Biopsy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cancer Biopsy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cancer Biopsy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cancer Biopsy Market Share by Region (2019-2024)

Table 9. Global Cancer Biopsy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cancer Biopsy Market Share by Region (2025-2030)

Table 11. Cancer Biopsy Market Trends

Table 12. Cancer Biopsy Market Drivers

Table 13. Cancer Biopsy Market Challenges

Table 14. Cancer Biopsy Market Restraints

Table 15. Global Cancer Biopsy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cancer Biopsy Market Share by Players (2019-2024)

Table 17. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2023)

Table 18. Ranking of Global Top Cancer Biopsy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Cancer Biopsy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Cancer Biopsy Product Solution and Service

Table 22. Date of Enter into Cancer Biopsy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cancer Biopsy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cancer Biopsy Revenue Market Share by Type (2019-2024)

Table 26. Global Cancer Biopsy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cancer Biopsy Revenue Market Share by Type (2025-2030)

Table 28. Global Cancer Biopsy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cancer Biopsy Revenue Market Share by Application (2019-2024)

Table 30. Global Cancer Biopsy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cancer Biopsy Revenue Market Share by Application (2025-2030)

Table 32. North America Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Cancer Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Cancer Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Cancer Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Cancer Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Cancer Biopsy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Cancer Biopsy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Cancer Biopsy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Cancer Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Cancer Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Cancer Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Cancer Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Qiagen N.V. Company Detail

Table 48. Qiagen N.V. Business Overview

Table 49. Qiagen N.V. Cancer Biopsy Product

Table 50. Qiagen N.V. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 51. Qiagen N.V. Recent Development

Table 52. Illumina, Inc. Company Detail

Table 53. Illumina, Inc. Business Overview

Table 54. Illumina, Inc. Cancer Biopsy Product

Table 55. Illumina, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 56. Illumina, Inc. Recent Development

Table 57. ANGLE Plc Company Detail

Table 58. ANGLE Plc Business Overview

Table 59. ANGLE Plc Cancer Biopsy Product

Table 60. ANGLE Plc Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 61. ANGLE Plc Recent Development

Table 62. Myriad Genetics Company Detail

Table 63. Myriad Genetics Business Overview

Table 64. Myriad Genetics Cancer Biopsy Product

Table 65. Myriad Genetics Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 66. Myriad Genetics Recent Development

Table 67. Hologic, Inc. Company Detail

Table 68. Hologic, Inc. Business Overview

Table 69. Hologic, Inc. Cancer Biopsy Product

Table 70. Hologic, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 71. Hologic, Inc. Recent Development

Table 72. Biocept, Inc. Company Detail

Table 73. Biocept, Inc. Business Overview

Table 74. Biocept, Inc. Cancer Biopsy Product

Table 75. Biocept, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 76. Biocept, Inc. Recent Development

Table 77. Thermo Fisher Scientific, Inc. Company Detail

Table 78. Thermo Fisher Scientific, Inc. Business Overview

Table 79. Thermo Fisher Scientific, Inc. Cancer Biopsy Product

Table 80. Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 81. Thermo Fisher Scientific, Inc. Recent Development

Table 82. Danaher Company Detail

Table 83. Danaher Business Overview

Table 84. Danaher Cancer Biopsy Product

Table 85. Danaher Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 86. Danaher Recent Development

Table 87. Lucence Diagnostics Pte. Ltd. Company Detail

Table 88. Lucence Diagnostics Pte. Ltd. Business Overview

Table 89. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product

Table 90. Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 91. Lucence Diagnostics Pte. Ltd. Recent Development

Table 92. GRAIL, Inc. Company Detail

Table 93. GRAIL, Inc. Business Overview

Table 94. GRAIL, Inc. Cancer Biopsy Product

Table 95. GRAIL, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 96. GRAIL, Inc. Recent Development

Table 97. Guardant Health Company Detail

Table 98. Guardant Health Business Overview

Table 99. Guardant Health Cancer Biopsy Product

Table 100. Guardant Health Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 101. Guardant Health Recent Development

Table 102. Exact Sciences Corporation Company Detail

Table 103. Exact Sciences Corporation Business Overview

Table 104. Exact Sciences Corporation Cancer Biopsy Product

Table 105. Exact Sciences Corporation Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 106. Exact Sciences Corporation Recent Development

Table 107. Freenome Holdings, Inc. Company Detail

Table 108. Freenome Holdings, Inc. Business Overview

Table 109. Freenome Holdings, Inc. Cancer Biopsy Product

Table 110. Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 111. Freenome Holdings, Inc. Recent Development

Table 112. Oncimmune Company Detail

Table 113. Oncimmune Business Overview

Table 114. Oncimmune Cancer Biopsy Product

Table 115. Oncimmune Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 116. Oncimmune Recent Development

Table 117. Chronix Biomedical, Inc. Company Detail

Table 118. Chronix Biomedical, Inc. Business Overview

Table 119. Chronix Biomedical, Inc. Cancer Biopsy Product

Table 120. Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 121. Chronix Biomedical, Inc. Recent Development

Table 122. Personal Genome Diagnostics Inc. Company Detail

Table 123. Personal Genome Diagnostics Inc. Business Overview

Table 124. Personal Genome Diagnostics Inc. Cancer Biopsy Product

Table 125. Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2019-2024) & (US$ Million)

Table 126. Personal Genome Diagnostics Inc. Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Biopsy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cancer Biopsy Market Share by Type: 2023 VS 2030

Figure 3. Tissue Biopsies Features

Figure 4. Liquid Biopsies Features

Figure 5. Others Features

Figure 6. Global Cancer Biopsy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cancer Biopsy Market Share by Application: 2023 VS 2030

Figure 8. Breast Cancer Case Studies

Figure 9. Colorectal Cancer Case Studies

Figure 10. Cervical Cancers Case Studies

Figure 11. Lung Cancers Case Studies

Figure 12. Prostate Cancers Case Studies

Figure 13. Skin Cancers Case Studies

Figure 14. Blood Cancers Case Studies

Figure 15. Kidney Cancers Case Studies

Figure 16. Others Case Studies

Figure 17. Cancer Biopsy Report Years Considered

Figure 18. Global Cancer Biopsy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Cancer Biopsy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Cancer Biopsy Market Share by Region: 2023 VS 2030

Figure 21. Global Cancer Biopsy Market Share by Players in 2023

Figure 22. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Cancer Biopsy Revenue in 2023

Figure 24. North America Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Cancer Biopsy Market Share by Country (2019-2030)

Figure 26. United States Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Cancer Biopsy Market Share by Country (2019-2030)

Figure 30. Germany Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Cancer Biopsy Market Share by Region (2019-2030)

Figure 38. China Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Cancer Biopsy Market Share by Country (2019-2030)

Figure 46. Mexico Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Cancer Biopsy Market Share by Country (2019-2030)

Figure 50. Turkey Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Cancer Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Qiagen N.V. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 53. Illumina, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 54. ANGLE Plc Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 55. Myriad Genetics Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 56. Hologic, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 57. Biocept, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 58. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 59. Danaher Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 60. Lucence Diagnostics Pte. Ltd. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 61. GRAIL, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 62. Guardant Health Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 63. Exact Sciences Corporation Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 64. Freenome Holdings, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 65. Oncimmune Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 66. Chronix Biomedical, Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 67. Personal Genome Diagnostics Inc. Revenue Growth Rate in Cancer Biopsy Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions